nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE5A—penis—type 1 diabetes mellitus	0.0198	0.0731	CbGeAlD
Dipyridamole—PDE3A—penis—type 1 diabetes mellitus	0.0193	0.0711	CbGeAlD
Dipyridamole—PDE6A—retina—type 1 diabetes mellitus	0.0178	0.0654	CbGeAlD
Dipyridamole—PDE6C—retina—type 1 diabetes mellitus	0.0168	0.062	CbGeAlD
Dipyridamole—PDE6B—retina—type 1 diabetes mellitus	0.0107	0.0393	CbGeAlD
Dipyridamole—PRUNE—nephron tubule—type 1 diabetes mellitus	0.0106	0.0389	CbGeAlD
Dipyridamole—PDE1C—cardiovascular system—type 1 diabetes mellitus	0.0105	0.0388	CbGeAlD
Dipyridamole—PDE6D—nephron tubule—type 1 diabetes mellitus	0.0102	0.0376	CbGeAlD
Dipyridamole—PDE6H—retina—type 1 diabetes mellitus	0.00992	0.0365	CbGeAlD
Dipyridamole—Stomach ache—Ramipril—type 1 diabetes mellitus	0.00973	0.0669	CcSEcCtD
Dipyridamole—PDE6G—retina—type 1 diabetes mellitus	0.00955	0.0352	CbGeAlD
Dipyridamole—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0082	0.0564	CcSEcCtD
Dipyridamole—PDE6B—lymphoid tissue—type 1 diabetes mellitus	0.00759	0.0279	CbGeAlD
Dipyridamole—PDE7A—kidney—type 1 diabetes mellitus	0.00732	0.0269	CbGeAlD
Dipyridamole—PDE8B—islet of Langerhans—type 1 diabetes mellitus	0.0072	0.0265	CbGeAlD
Dipyridamole—PDE3B—islet of Langerhans—type 1 diabetes mellitus	0.00703	0.0259	CbGeAlD
Dipyridamole—PDE8A—islet of Langerhans—type 1 diabetes mellitus	0.00647	0.0238	CbGeAlD
Dipyridamole—PDE7A—lymphoid tissue—type 1 diabetes mellitus	0.00629	0.0231	CbGeAlD
Dipyridamole—PDE10A—nephron tubule—type 1 diabetes mellitus	0.00607	0.0224	CbGeAlD
Dipyridamole—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.00554	0.0381	CcSEcCtD
Dipyridamole—PDE2A—cardiovascular system—type 1 diabetes mellitus	0.00546	0.0201	CbGeAlD
Dipyridamole—PDE8A—nephron tubule—type 1 diabetes mellitus	0.00521	0.0192	CbGeAlD
Dipyridamole—PDE3B—cardiovascular system—type 1 diabetes mellitus	0.00508	0.0187	CbGeAlD
Dipyridamole—PDE1A—nephron tubule—type 1 diabetes mellitus	0.00504	0.0186	CbGeAlD
Dipyridamole—PDE3B—pancreas—type 1 diabetes mellitus	0.00494	0.0182	CbGeAlD
Dipyridamole—PDE8A—pancreas—type 1 diabetes mellitus	0.00455	0.0168	CbGeAlD
Dipyridamole—PDE1A—cardiovascular system—type 1 diabetes mellitus	0.00453	0.0167	CbGeAlD
Dipyridamole—PDE1A—kidney—type 1 diabetes mellitus	0.00443	0.0163	CbGeAlD
Dipyridamole—ADA—cardiovascular system—type 1 diabetes mellitus	0.00385	0.0142	CbGeAlD
Dipyridamole—PDE5A—retina—type 1 diabetes mellitus	0.00377	0.0139	CbGeAlD
Dipyridamole—SLC29A1—islet of Langerhans—type 1 diabetes mellitus	0.00371	0.0136	CbGeAlD
Dipyridamole—ABCC5—retina—type 1 diabetes mellitus	0.00345	0.0127	CbGeAlD
Dipyridamole—ABCC5—nephron tubule—type 1 diabetes mellitus	0.00325	0.012	CbGeAlD
Dipyridamole—ADA—lymphoid tissue—type 1 diabetes mellitus	0.00324	0.0119	CbGeAlD
Dipyridamole—PDE5A—cardiovascular system—type 1 diabetes mellitus	0.00319	0.0118	CbGeAlD
Dipyridamole—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00317	0.0218	CcSEcCtD
Dipyridamole—PDE3A—cardiovascular system—type 1 diabetes mellitus	0.00311	0.0114	CbGeAlD
Dipyridamole—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.0031	0.0213	CcSEcCtD
Dipyridamole—Arthritis—Ramipril—type 1 diabetes mellitus	0.00309	0.0213	CcSEcCtD
Dipyridamole—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00306	0.0211	CcSEcCtD
Dipyridamole—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00274	0.0189	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00274	0.0189	CcSEcCtD
Dipyridamole—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.0027	0.0186	CcSEcCtD
Dipyridamole—SLC29A1—cardiovascular system—type 1 diabetes mellitus	0.00268	0.00987	CbGeAlD
Dipyridamole—SLC29A1—kidney—type 1 diabetes mellitus	0.00262	0.00966	CbGeAlD
Dipyridamole—SLC29A1—pancreas—type 1 diabetes mellitus	0.00261	0.00959	CbGeAlD
Dipyridamole—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00259	0.0179	CcSEcCtD
Dipyridamole—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00255	0.0176	CcSEcCtD
Dipyridamole—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00253	0.0174	CcSEcCtD
Dipyridamole—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00253	0.0174	CcSEcCtD
Dipyridamole—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00249	0.0171	CcSEcCtD
Dipyridamole—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00228	0.0157	CcSEcCtD
Dipyridamole—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00227	0.0156	CcSEcCtD
Dipyridamole—ABCC4—nephron tubule—type 1 diabetes mellitus	0.00225	0.0083	CbGeAlD
Dipyridamole—SLC29A1—lymphoid tissue—type 1 diabetes mellitus	0.00225	0.00829	CbGeAlD
Dipyridamole—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00208	0.0143	CcSEcCtD
Dipyridamole—ABCC4—kidney—type 1 diabetes mellitus	0.00198	0.00729	CbGeAlD
Dipyridamole—ABCC4—pancreas—type 1 diabetes mellitus	0.00197	0.00724	CbGeAlD
Dipyridamole—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00194	0.0133	CcSEcCtD
Dipyridamole—Flushing—Ramipril—type 1 diabetes mellitus	0.00193	0.0133	CcSEcCtD
Dipyridamole—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00188	0.0129	CcSEcCtD
Dipyridamole—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00187	0.0129	CcSEcCtD
Dipyridamole—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00186	0.0128	CcSEcCtD
Dipyridamole—Alopecia—Ramipril—type 1 diabetes mellitus	0.00184	0.0126	CcSEcCtD
Dipyridamole—Tension—Ramipril—type 1 diabetes mellitus	0.00177	0.0122	CcSEcCtD
Dipyridamole—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00177	0.0122	CcSEcCtD
Dipyridamole—Nervousness—Ramipril—type 1 diabetes mellitus	0.00176	0.0121	CcSEcCtD
Dipyridamole—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00174	0.012	CcSEcCtD
Dipyridamole—Tremor—Ramipril—type 1 diabetes mellitus	0.00169	0.0117	CcSEcCtD
Dipyridamole—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00168	0.0115	CcSEcCtD
Dipyridamole—Angioedema—Ramipril—type 1 diabetes mellitus	0.00165	0.0114	CcSEcCtD
Dipyridamole—Malaise—Ramipril—type 1 diabetes mellitus	0.00163	0.0112	CcSEcCtD
Dipyridamole—Vertigo—Ramipril—type 1 diabetes mellitus	0.00162	0.0112	CcSEcCtD
Dipyridamole—Syncope—Ramipril—type 1 diabetes mellitus	0.00162	0.0112	CcSEcCtD
Dipyridamole—Palpitations—Ramipril—type 1 diabetes mellitus	0.0016	0.011	CcSEcCtD
Dipyridamole—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00159	0.0109	CcSEcCtD
Dipyridamole—Cough—Ramipril—type 1 diabetes mellitus	0.00158	0.0109	CcSEcCtD
Dipyridamole—Convulsion—Ramipril—type 1 diabetes mellitus	0.00157	0.0108	CcSEcCtD
Dipyridamole—Chest pain—Ramipril—type 1 diabetes mellitus	0.00154	0.0106	CcSEcCtD
Dipyridamole—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00154	0.0106	CcSEcCtD
Dipyridamole—Myalgia—Ramipril—type 1 diabetes mellitus	0.00154	0.0106	CcSEcCtD
Dipyridamole—Anxiety—Ramipril—type 1 diabetes mellitus	0.00153	0.0106	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00153	0.0105	CcSEcCtD
Dipyridamole—Discomfort—Ramipril—type 1 diabetes mellitus	0.00152	0.0105	CcSEcCtD
Dipyridamole—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00151	0.0104	CcSEcCtD
Dipyridamole—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00148	0.0102	CcSEcCtD
Dipyridamole—Oedema—Ramipril—type 1 diabetes mellitus	0.00148	0.0102	CcSEcCtD
Dipyridamole—Shock—Ramipril—type 1 diabetes mellitus	0.00145	0.00999	CcSEcCtD
Dipyridamole—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00145	0.00996	CcSEcCtD
Dipyridamole—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00144	0.00994	CcSEcCtD
Dipyridamole—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00144	0.00991	CcSEcCtD
Dipyridamole—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00143	0.00986	CcSEcCtD
Dipyridamole—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00143	0.00982	CcSEcCtD
Dipyridamole—Hypotension—Ramipril—type 1 diabetes mellitus	0.00138	0.00949	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00134	0.00925	CcSEcCtD
Dipyridamole—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00132	0.00912	CcSEcCtD
Dipyridamole—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00132	0.00905	CcSEcCtD
Dipyridamole—Somnolence—Ramipril—type 1 diabetes mellitus	0.00131	0.00903	CcSEcCtD
Dipyridamole—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.0013	0.00894	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00127	0.00877	CcSEcCtD
Dipyridamole—Fatigue—Ramipril—type 1 diabetes mellitus	0.00127	0.00875	CcSEcCtD
Dipyridamole—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00122	0.00837	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00121	0.0083	CcSEcCtD
Dipyridamole—Urticaria—Ramipril—type 1 diabetes mellitus	0.00117	0.00807	CcSEcCtD
Dipyridamole—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00117	0.00803	CcSEcCtD
Dipyridamole—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00109	0.00748	CcSEcCtD
Dipyridamole—Asthenia—Ramipril—type 1 diabetes mellitus	0.00106	0.00729	CcSEcCtD
Dipyridamole—Pruritus—Ramipril—type 1 diabetes mellitus	0.00104	0.00718	CcSEcCtD
Dipyridamole—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00101	0.00695	CcSEcCtD
Dipyridamole—Dizziness—Ramipril—type 1 diabetes mellitus	0.000976	0.00671	CcSEcCtD
Dipyridamole—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000974	0.00359	CbGeAlD
Dipyridamole—Vomiting—Ramipril—type 1 diabetes mellitus	0.000938	0.00646	CcSEcCtD
Dipyridamole—Rash—Ramipril—type 1 diabetes mellitus	0.00093	0.0064	CcSEcCtD
Dipyridamole—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000929	0.0064	CcSEcCtD
Dipyridamole—Headache—Ramipril—type 1 diabetes mellitus	0.000924	0.00636	CcSEcCtD
Dipyridamole—Nausea—Ramipril—type 1 diabetes mellitus	0.000876	0.00603	CcSEcCtD
Dipyridamole—ABCB1—retina—type 1 diabetes mellitus	0.000833	0.00307	CbGeAlD
Dipyridamole—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000784	0.00289	CbGeAlD
Dipyridamole—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000705	0.00259	CbGeAlD
Dipyridamole—ABCB1—kidney—type 1 diabetes mellitus	0.000689	0.00254	CbGeAlD
Dipyridamole—ABCB1—pancreas—type 1 diabetes mellitus	0.000685	0.00252	CbGeAlD
Dipyridamole—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000592	0.00218	CbGeAlD
Dipyridamole—PDE1B—Disease—ERBB3—type 1 diabetes mellitus	5.15e-05	8.83e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CD86—type 1 diabetes mellitus	5.11e-05	8.76e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CRP—type 1 diabetes mellitus	5.1e-05	8.75e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CCR5—type 1 diabetes mellitus	5.06e-05	8.69e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.05e-05	8.67e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—STAT3—type 1 diabetes mellitus	5.05e-05	8.67e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	5.01e-05	8.6e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	5e-05	8.58e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.99e-05	8.55e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—STAT3—type 1 diabetes mellitus	4.99e-05	8.55e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.98e-05	8.55e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—EGFR—type 1 diabetes mellitus	4.97e-05	8.53e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.96e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.96e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—INS—type 1 diabetes mellitus	4.96e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HLA-A—type 1 diabetes mellitus	4.94e-05	8.46e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD80—type 1 diabetes mellitus	4.93e-05	8.46e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.92e-05	8.45e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.92e-05	8.45e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—GCG—type 1 diabetes mellitus	4.91e-05	8.41e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.89e-05	8.39e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	4.89e-05	8.39e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.89e-05	8.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-DRB1—type 1 diabetes mellitus	4.88e-05	8.38e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.88e-05	8.37e-05	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.88e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.86e-05	8.33e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.86e-05	8.33e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.85e-05	8.31e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.85e-05	8.31e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.83e-05	8.28e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CD86—type 1 diabetes mellitus	4.78e-05	8.2e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.77e-05	8.18e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	4.72e-05	8.1e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOS2—type 1 diabetes mellitus	4.69e-05	8.05e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOS2—type 1 diabetes mellitus	4.69e-05	8.05e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CD86—type 1 diabetes mellitus	4.65e-05	7.98e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.61e-05	7.9e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.61e-05	7.9e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.6e-05	7.9e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—EGFR—type 1 diabetes mellitus	4.59e-05	7.88e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.59e-05	7.87e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—IL2—type 1 diabetes mellitus	4.58e-05	7.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.57e-05	7.84e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.57e-05	7.83e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.56e-05	7.82e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD80—type 1 diabetes mellitus	4.55e-05	7.81e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD80—type 1 diabetes mellitus	4.55e-05	7.81e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—EGFR—type 1 diabetes mellitus	4.55e-05	7.8e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—ALB—type 1 diabetes mellitus	4.55e-05	7.8e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.54e-05	7.79e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.54e-05	7.79e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.54e-05	7.79e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.54e-05	7.78e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.54e-05	7.78e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.54e-05	7.78e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—EGFR—type 1 diabetes mellitus	4.53e-05	7.77e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.53e-05	7.77e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.51e-05	7.74e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.51e-05	7.74e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD80—type 1 diabetes mellitus	4.51e-05	7.74e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.49e-05	7.7e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.46e-05	7.65e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.44e-05	7.62e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.43e-05	7.6e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	4.43e-05	7.59e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.41e-05	7.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CD86—type 1 diabetes mellitus	4.37e-05	7.5e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—NOS3—type 1 diabetes mellitus	4.35e-05	7.46e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.31e-05	7.39e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—INS—type 1 diabetes mellitus	4.3e-05	7.38e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—INS—type 1 diabetes mellitus	4.3e-05	7.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOS2—type 1 diabetes mellitus	4.29e-05	7.36e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.24e-05	7.27e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.21e-05	7.22e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.21e-05	7.21e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.19e-05	7.19e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.19e-05	7.18e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.19e-05	7.18e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.18e-05	7.18e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.18e-05	7.17e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.18e-05	7.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.17e-05	7.15e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD80—type 1 diabetes mellitus	4.17e-05	7.14e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—TYK2—type 1 diabetes mellitus	4.16e-05	7.14e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	4.16e-05	7.14e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—EGFR—type 1 diabetes mellitus	4.16e-05	7.14e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.16e-05	7.13e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.15e-05	7.12e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.15e-05	7.12e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL2—type 1 diabetes mellitus	4.15e-05	7.12e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.15e-05	7.11e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.12e-05	7.07e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.11e-05	7.04e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.08e-05	7e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.06e-05	6.97e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.05e-05	6.94e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.04e-05	6.93e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.03e-05	6.92e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.02e-05	6.9e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CD86—type 1 diabetes mellitus	4e-05	6.86e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	3.97e-05	6.8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.94e-05	6.76e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—INS—type 1 diabetes mellitus	3.94e-05	6.75e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IFNG—type 1 diabetes mellitus	3.9e-05	6.69e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.88e-05	6.65e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TYK2—type 1 diabetes mellitus	3.84e-05	6.59e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TYK2—type 1 diabetes mellitus	3.84e-05	6.59e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—type 1 diabetes mellitus	3.82e-05	6.56e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.82e-05	6.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.82e-05	6.55e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.82e-05	6.55e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.82e-05	6.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—TYK2—type 1 diabetes mellitus	3.81e-05	6.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.79e-05	6.51e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.79e-05	6.5e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.78e-05	6.49e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.78e-05	6.49e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOS3—type 1 diabetes mellitus	3.77e-05	6.47e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOS3—type 1 diabetes mellitus	3.77e-05	6.47e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD4—type 1 diabetes mellitus	3.77e-05	6.46e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.73e-05	6.4e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CD80—type 1 diabetes mellitus	3.72e-05	6.39e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	3.61e-05	6.19e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.61e-05	6.18e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—INS—type 1 diabetes mellitus	3.6e-05	6.18e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IFNG—type 1 diabetes mellitus	3.57e-05	6.12e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.55e-05	6.08e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.54e-05	6.07e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—type 1 diabetes mellitus	3.53e-05	6.05e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—INS—type 1 diabetes mellitus	3.52e-05	6.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TYK2—type 1 diabetes mellitus	3.52e-05	6.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—type 1 diabetes mellitus	3.5e-05	6e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.5e-05	5.99e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.49e-05	5.99e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.49e-05	5.98e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—type 1 diabetes mellitus	3.48e-05	5.97e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1B—type 1 diabetes mellitus	3.48e-05	5.97e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD4—type 1 diabetes mellitus	3.48e-05	5.96e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD4—type 1 diabetes mellitus	3.48e-05	5.96e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.47e-05	5.95e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.47e-05	5.95e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.47e-05	5.95e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL2—type 1 diabetes mellitus	3.47e-05	5.94e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOS3—type 1 diabetes mellitus	3.45e-05	5.92e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD4—type 1 diabetes mellitus	3.44e-05	5.91e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.4e-05	5.84e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.4e-05	5.84e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.39e-05	5.82e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.39e-05	5.81e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ALB—type 1 diabetes mellitus	3.3e-05	5.67e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—INS—type 1 diabetes mellitus	3.3e-05	5.65e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.22e-05	5.52e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.22e-05	5.52e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.22e-05	5.52e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—INS—type 1 diabetes mellitus	3.21e-05	5.5e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—type 1 diabetes mellitus	3.2e-05	5.49e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.19e-05	5.47e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.19e-05	5.47e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1B—type 1 diabetes mellitus	3.18e-05	5.46e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD4—type 1 diabetes mellitus	3.18e-05	5.45e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.17e-05	5.44e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.17e-05	5.44e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL2—type 1 diabetes mellitus	3.17e-05	5.44e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—NOS3—type 1 diabetes mellitus	3.16e-05	5.42e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.14e-05	5.39e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.14e-05	5.38e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.1e-05	5.32e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.09e-05	5.3e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.09e-05	5.29e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.09e-05	5.29e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	3.03e-05	5.19e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—INS—type 1 diabetes mellitus	3.01e-05	5.17e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.94e-05	5.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CD80—type 1 diabetes mellitus	2.92e-05	5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—STAT3—type 1 diabetes mellitus	2.92e-05	5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.92e-05	5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.9e-05	4.97e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.89e-05	4.96e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.88e-05	4.95e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.87e-05	4.92e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.86e-05	4.91e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.85e-05	4.89e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.81e-05	4.82e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—INS—type 1 diabetes mellitus	2.76e-05	4.73e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.69e-05	4.62e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—STAT3—type 1 diabetes mellitus	2.69e-05	4.62e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—STAT3—type 1 diabetes mellitus	2.69e-05	4.62e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—STAT3—type 1 diabetes mellitus	2.67e-05	4.57e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.67e-05	4.57e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.67e-05	4.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.67e-05	4.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.65e-05	4.55e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—type 1 diabetes mellitus	2.65e-05	4.55e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.64e-05	4.53e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.62e-05	4.49e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2—type 1 diabetes mellitus	2.62e-05	4.49e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.6e-05	4.46e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.47e-05	4.24e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.46e-05	4.22e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—type 1 diabetes mellitus	2.46e-05	4.22e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.45e-05	4.21e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.45e-05	4.2e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—type 1 diabetes mellitus	2.45e-05	4.2e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—type 1 diabetes mellitus	2.45e-05	4.2e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—type 1 diabetes mellitus	2.44e-05	4.18e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.44e-05	4.18e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—type 1 diabetes mellitus	2.42e-05	4.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.42e-05	4.15e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	2.41e-05	4.13e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.39e-05	4.09e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.38e-05	4.09e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.38e-05	4.08e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.37e-05	4.07e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	2.27e-05	3.89e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	2.25e-05	3.86e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.24e-05	3.85e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.24e-05	3.84e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—type 1 diabetes mellitus	2.24e-05	3.84e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.23e-05	3.82e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	2.21e-05	3.79e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.2e-05	3.78e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.06e-05	3.54e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.05e-05	3.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—type 1 diabetes mellitus	2.05e-05	3.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.04e-05	3.5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—type 1 diabetes mellitus	2.04e-05	3.49e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.01e-05	3.44e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2e-05	3.43e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.94e-05	3.33e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.89e-05	3.23e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—type 1 diabetes mellitus	1.88e-05	3.23e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—type 1 diabetes mellitus	1.88e-05	3.23e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.87e-05	3.21e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—type 1 diabetes mellitus	1.86e-05	3.2e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.82e-05	3.13e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.76e-05	3.02e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.72e-05	2.96e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—type 1 diabetes mellitus	1.72e-05	2.95e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.71e-05	2.94e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.57e-05	2.69e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.54e-05	2.64e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.49e-05	2.56e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.44e-05	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.4e-05	2.4e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.32e-05	2.26e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.2e-05	2.07e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—INS—type 1 diabetes mellitus	9.91e-06	1.7e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	9.08e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	8.69e-06	1.49e-05	CbGpPWpGaD
